TrialJournal of child and adolescent psychopharmacology2017

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.

Ann C Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.